12-12-2025 18:04 via medpagetoday.com

Pre-Op MRI Shows 'No Clinical Benefit' in Early Breast Cancer

(MedPage Today) -- SAN ANTONIO--Preoperative MRI for staging patients with early, hormone receptor (HR)-negative breast cancer didn't result in improved oncologic outcomes or improved clinical care, according to a phase III study presented...
Read more »

Medical Industry news



Lung Cancer Screening Follow-Up Often Inadequate
Blockbuster Drug Lands First-Line Indication for HER2-Positive Breast Cancer
Second Oral Antibiotic for Gonorrhea Gets FDA Green Light
Women Getting Bad Advice on Cannabis Use in Pregnancy, Study Finds
Burden of Postpartum Hemorrhage May Be Greater Than Previously Thought
Look to the States to Lead on Public Health
Walking Away With Purpose …
Myeloma Combination Cuts Line for FDA Approval After Strong ASH Results
Akeega Approved for BRCA2-Mutated Prostate Cancer
Etripamil Gets FDA Approval for At-Home Tachycardia Conversion
Novel Pills Promising in Relapsed/Refractory Multiple Myeloma
Longevity Forever!
Outcomes Remain Poor in Blast-Phase CML, Despite Modern TKIs
Awareness of BRCA Status Drives Aggressive Surgery in Early-Onset Breast Cancer
Desktop versie